Why Is Beclomethasone (Qvar) So Hard to Find? [Explained for 2026]

You went to pick up your Beclomethasone inhaler — Qvar RediHaler — and were told it's not in stock. You called a few other pharmacies and got the same answer. So what's going on?

The short answer: Beclomethasone (sold as Qvar RediHaler) has no generic version, is made by a single manufacturer, and is experiencing pharmacy-level stock-outs across the country in 2026 — even though there is no official FDA-declared shortage. This guide breaks down exactly why that happens and what you can do about it.

Is Beclomethasone in a Shortage Right Now?

As of 2026, Qvar RediHaler (Beclomethasone Dipropionate HFA) is not officially listed on the FDA's drug shortage database. That's the good news. But "not in shortage" at the national level doesn't mean your local pharmacy has it on the shelf.

Patients across the country have reported intermittent difficulty finding Qvar RediHaler since late 2024 and into 2026. These pharmacy-level stock-outs can feel exactly like a shortage — because for you, it is. The issue is uneven distribution: some pharmacies have it, others don't.

Why Does Beclomethasone Have Availability Problems?

Several factors combine to make Beclomethasone harder to find than it should be:

1. There Is Only One Manufacturer

Qvar RediHaler is made exclusively by Teva Pharmaceuticals (at their Norton Waterford facility in Ireland). There is no generic version, and patents on the RediHaler device don't expire until around May 2031. When a single company is the sole source for a medication, any manufacturing delay, distribution hiccup, or demand surge affects the entire supply chain — there's no backup.

2. Demand Surges from Other ICS Shortages

The inhaled corticosteroid (ICS) market has been disrupted by a cascade of events. In January 2024, GSK discontinued brand-name Flovent (fluticasone) inhalers. Around the same time, budesonide (Pulmicort) inhalation suspension went into active shortage. These disruptions sent patients and prescribers searching for alternatives — and Beclomethasone (Qvar) was a common choice. That surge in demand put pressure on Teva's supply that hasn't fully eased.

3. Inhalers Are Complicated to Manufacture

Qvar RediHaler is a breath-actuated metered-dose inhaler (BA-MDI) — a more complex device than a standard inhaler. The device requires specialized manufacturing lines and strict quality controls. Unlike a tablet or simple liquid, you can't just scale up production overnight. The devices must be assembled, filled, tested, and shipped under strict conditions.

4. Seasonal Demand Spikes

Asthma symptoms — and thus demand for controller inhalers — spike during winter respiratory virus season and spring allergy season. During these peaks, even a medication with adequate overall supply can become temporarily hard to find at individual pharmacies that haven't stocked up sufficiently.

5. Uneven Pharmacy Distribution

Large chain pharmacies often order from central wholesalers on predictable schedules. When a product is in higher demand than usual, regional distribution centers can run low — leaving individual pharmacy locations without stock even when the manufacturer has product available. Independent pharmacies and specialty pharmacies often have more flexibility in sourcing and may have stock when chains don't.

What Can You Do If You Can't Find Beclomethasone?

Here are concrete steps to take right now:

Use medfinder to locate pharmacies with Beclomethasone in stock. Instead of calling pharmacy after pharmacy yourself, medfinder calls pharmacies near you to find which ones can fill your prescription. Visit medfinder.com to get started.

Try independent pharmacies. Independent and specialty pharmacies often use different wholesale suppliers than large chains and may have stock available when CVS, Walgreens, or Rite Aid are out.

Ask your pharmacy to place a special order. Many pharmacies can order specific medications from their wholesaler, though it may take 1-3 business days.

Refill early. Don't wait until your last dose. Most insurance plans allow refills when you have 7-10 days left. Refilling early gives you time to find a stocked pharmacy.

Talk to your doctor about a temporary alternative. If you can't find Qvar, ask your doctor about other ICS options like generic fluticasone propionate, budesonide, mometasone, or ciclesonide. These work similarly to Beclomethasone for asthma maintenance.

Never abruptly stop your controller inhaler. Stopping an inhaled corticosteroid suddenly can trigger asthma flare-ups. If you're running low, contact your doctor immediately.

Will the Situation Improve?

Since there is no FDA-declared shortage, there is no formal government action forcing Teva to increase output. The availability of Qvar depends entirely on Teva's production schedule and distribution network. Until a generic alternative to Qvar RediHaler reaches the market (not expected until 2031 at the earliest), patients will continue to deal with variable pharmacy-level availability.

The good news: the situation is manageable. The key is being proactive — refilling early, knowing your alternatives, and using tools like medfinder to quickly find a pharmacy that has your medication.

Bottom Line

Beclomethasone availability issues in 2026 are real but not insurmountable. The single-manufacturer status and lack of a generic create fragility in the supply chain, but most patients who can't find it at one pharmacy will find it at another. Use medfinder to take the legwork out of the search. For more strategies, see our guides on how to find Beclomethasone in stock near you and alternatives to Beclomethasone.